Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin add-on to metformin plus pioglitazone in type 2 diabetes
2009-013289-20Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Linagliptin add-on arm with Placebo add-on arm (2 arms). Primary endpoint: Change from baseline in HbA1c at 24 weeks. Started Sep 2009; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-013289-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013289-20.